Athenahealth, Inc. (ATHN) Reports In-Line Q3 EPS

Athenahealth, Inc. (NASDAQ: ATHN) reported Q3 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $190.4 million versus the consensus estimate of $190.4 million.

Athenahealth, Inc. sees FY2014 EPS of $0.98-$1.10, versus the consensus of $1.09. Athenahealth, Inc. sees FY2014 revenue of $725-755 million, versus the consensus of $746.65 million.

"We continued to see strong momentum across the business in the third quarter, with record physician additions, the opening of two extraordinary offices in Atlanta and San Francisco, the launch of a brand new user experience across our client base, and industry-leading Meaningful Use Stage 2 attestation results," said Jonathan Bush, chairman and chief executive officer of athenahealth. "As we prepare for the next wave of growth, we are intently focused on achieving the ambitious goals we laid out for 2014, as well as refining our 2015 roadmap and priorities."

For earnings history and earnings-related data on Athenahealth, Inc. (ATHN) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• NextEra Energy (NEE) Tops Q1 EPS by 16c, provides guidance
• Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q1 EPS by 11c; raises guidance